Abstract PO-219: The implications of genetic ancestry and allostatic load on clinical outcomes in the ECOG-ACRIN adjuvant breast cancer trial E5103

MLA

Samilia Obeng-Gyasi, et al. “Abstract PO-219: The Implications of Genetic Ancestry and Allostatic Load on Clinical Outcomes in the ECOG-ACRIN Adjuvant Breast Cancer Trial E5103.” Cancer Epidemiology, Biomarkers & Prevention, vol. 31, Jan. 2022, p. PO-219. EBSCOhost, https://doi.org/10.1158/1538-7755.disp21-po-219.

APA

Samilia Obeng-Gyasi, Anne ONeill, Kathy D. Miller, Bryan P. Schneider, Ann H. Patridge, Lava R. Timsina, George W. Sledge, Lynne Wagner, & Ruth C. Carlos. (2022). Abstract PO-219: The implications of genetic ancestry and allostatic load on clinical outcomes in the ECOG-ACRIN adjuvant breast cancer trial E5103. Cancer Epidemiology, Biomarkers & Prevention, 31, PO-219. https://doi.org/10.1158/1538-7755.disp21-po-219

Chicago

Samilia Obeng-Gyasi, Anne ONeill, Kathy D. Miller, Bryan P. Schneider, Ann H. Patridge, Lava R. Timsina, George W. Sledge, Lynne Wagner, and Ruth C. Carlos. 2022. “Abstract PO-219: The Implications of Genetic Ancestry and Allostatic Load on Clinical Outcomes in the ECOG-ACRIN Adjuvant Breast Cancer Trial E5103.” Cancer Epidemiology, Biomarkers & Prevention 31 (January): PO-219. doi:10.1158/1538-7755.disp21-po-219.